Journal of Clinical Oncology
In Reply.
Journal of Clinical Oncology
Reply to H. Zetterberg et al.
Journal of Clinical Oncology
Interim results of a phase I trial of intraventricular rituximab plus methotrexate in recurrent CNS lymphoma: Macrophage polarization and acquired resistance to therapy.
Journal of Clinical Oncology
Suppressive signals in colorectal cancer: RasGRP1 a new marker for anti-EGFR therapy?.
Journal of Clinical Oncology
Phase I investigation of lenalidomide plus rituximab and outcomes of lenalidomide maintenance in recurrent CNS lymphoma.
Journal of Clinical Oncology
Gene expression signature associated with in vitro dexamethasone resistance and post-induction minimal residual disease in pediatric T-cell acute lymphoblastic leukemia.
Journal of Clinical Oncology
Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of induction therapy in Alliance 51101.
Journal of Clinical Oncology